Discussions
Discussions
BeClearwithBronchiectasis Check-In 07/25/2025
ARINA-1 (nebulized treatment for bronchiectasis) UPDATE
Many people have been asking about ARINA-1, a promising proprietary nebulized solution in development for respiratory diseases.
What is ARINA-1?
ARINA-1 is an investigational, at-home nebulized therapy designed to:
*Thin mucus to improve airway clearance
*Reduce airway inflammation without the side effects of steroids
*Inhibit harmful bacteria, including those linked to recurrent infections
In 2024, Renovion completed a randomized, phase 2, double-blind, placebo-controlled study evaluating the safety and efficacy of ARINA-1 in people with non-cystic fibrosis bronchiectasis (NCFBE). Early clinical results suggest ARINA-1 begins working within days and delivers promising outcomes.
If approved, it could become the first non-antibiotic nebulized therapy specifically for bronchiectasis—addressing a critical unmet need for patients.
I’ll continue to follow ARINA-1’s development and will share updates as more information becomes available.
Warm regards,
Linda Esposito
Replies
Linda,
Thank you for sharing this update. It is great to witness the expansion of research for BNTM drug development.This drug and other drugs in the pipeline offer the BNTM the gift 🎁 of HOPE.
Thanks Linda👍
It is not our intention to serve as a substitute for medical advice and any content posted should not be used for medical advice, diagnosis or treatment. We make every effort to support our members, our medical professionals cannot and will not provide a diagnosis or suggest a specific medication; those decisions should be left to your personal medical team. While we encourage individuals to share their personal experiences with COPD, please consult a physician before making changes to your own COPD management plan.
Community posts are monitored by the 360social Community Manager, as well as staff respiratory therapists, educators, and other medical professionals.